Varex Imaging Corp
VREX Nasdaq Electronic Components, Nec Financials FY2016–FY2025
Last close · Oct 23, 2026
$18.42
0.1%What Varex Imaging Corp does
No business description yet.
- Legal name
- Varex Imaging Corp
- Fiscal year ends
- October 3, 2025
- Latest annual report
- 10-K · Nov 18, 2025
- Accession · CIK
- 0001681622-25-000108
0001681622
Revenue and margins
Varex Imaging Corp had $845M of revenue in fiscal 2025, up 4.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $18.8M in fiscal 2025, 2.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Varex Imaging Corp returned — to shareholders in fiscal 2025. The diluted share count rose 1.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Varex Imaging Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $145M | $89.4M | $194M | $201M | $155M |
| Debt incl. finance leases | $435M | $415M | $443M | $450M | $374M |
| Net debt / EBITDA | 3.1x | 3.0x | 2.6x | 4.7x | — |
| Debt / equity | 0.9x | 0.8x | 0.8x | 0.8x | 0.8x |
| Interest coverage | 1.8x | 2.2x | 2.6x | 1.1x | −0.8x |
| Current ratio | 3.3x | 3.5x | 4.0x | 3.3x | 3.4x |
| Quick ratio | 2.0x | 1.8x | 2.3x | 2.0x | 1.8x |
| Total assets | $1.1B | $1.2B | $1.2B | $1.2B | $1.1B |
| Total liabilities | $651M | $638M | $669M | $670M | $621M |
| Shareholders' equity | $483M | $533M | $568M | $529M | $473M |
| Net debt (− = net cash) | $290M | $325M | $249M | $249M | $218M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ |
| Current ratio rose | — | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ |
| Gross margin rose | — | ✕ | ✕ | ✓ | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ |
| F-score | — / 3 | 3 / 9 | 5 / 9 | 5 / 9 | 3 / 9 | 8 / 9 | 6 / 9 | 5 / 9 | 3 / 9 | 6 / 9 |
| Accruals ratio | −0.9% | −2.8% | −5.7% | −5.6% | −6.5% | −6.6% | 1.1% | −5.0% | −7.8% | −9.7% |
| Altman Z'' | 10.57 | 3.43 | 3.36 | 3.00 | 2.63 | 3.52 | 3.97 | 4.22 | 3.63 | 3.31 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $620M | $698M | $773M | $781M | $738M | $818M | $859M | $893M | $811M | $845M |
| Gross profit | $248M | $254M | $254M | $257M | $190M | $272M | $284M | $290M | $257M | $291M |
| Research and development | $53.5M | $67.3M | $83.0M | $78.1M | $78.9M | $71.9M | $77.0M | $84.8M | $87.0M | $91.1M |
| Operating income | $109M | $83.7M | $44.5M | $45.7M | −$33.7M | $74.1M | $88.2M | $77.1M | $32.1M | −$27.8M |
| Interest expense | $1.9M | $12.3M | $21.7M | $21.1M | $31.4M | $42.1M | $39.8M | $29.3M | $30.2M | $35.5M |
| Pretax income | $105M | $74.8M | $25.7M | $21.5M | −$72.6M | $28.6M | $44.5M | $31.3M | $5.0M | −$59.2M |
| Income tax | $36.0M | $22.8M | −$2.6M | $5.7M | −$15.2M | $10.7M | $13.7M | −$16.6M | $53.3M | $10.7M |
| Net income | $68.5M | $51.6M | $27.5M | $15.5M | −$57.9M | $17.4M | $30.3M | $47.4M | −$48.8M | −$70.3M |
| Net income to common | — | — | — | — | −$57.9M | $17.4M | $30.3M | — | — | — |
| Diluted EPS | $1.82 | $1.36 | $0.72 | $0.40 | −$1.49 | $0.43 | $0.73 | $1.07 | −$1.20 | −$1.70 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $74.2M | $75.2M | $85.3M | $71.9M | $13.2M | $92.6M | $16.9M | $108M | $47.3M | $41.7M |
| Capital expenditure | $28.9M | $20.2M | $20.4M | $19.8M | $23.5M | $15.1M | $21.3M | $20.7M | $26.9M | $22.9M |
| Free cash flow | $45.3M | $55.0M | $64.9M | $52.1M | −$10.3M | $77.5M | −$4.4M | $87.7M | $20.4M | $18.8M |
| Depreciation and amortization | $9.8M | $16.9M | $26.0M | $23.5M | $22.3M | $20.5M | $19.0M | $19.5M | $21.2M | $23.2M |
| Stock-based compensation | $9.5M | $8.4M | $10.0M | $11.7M | $13.4M | $13.9M | $14.0M | $13.5M | $15.3M | $15.0M |
| Acquisitions | $1.2M | $272M | $4.8M | $69.5M | $1.6M | $0.0M | $0.0M | $1.0M | −$0.9M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $36.5M | $83.3M | $51.9M | $29.9M | $101M | $145M | $89.4M | $194M | $201M | $155M |
| Total debt | $0.0M | $484M | $390M | $395M | $455M | $435M | $414M | $443M | $443M | $368M |
| Finance lease liabilities | — | — | — | — | $0.6M | $0.5M | $0.3M | $0.3M | $6.3M | $6.0M |
| Current assets | $360M | $495M | $458M | $438M | $522M | $554M | $610M | $658M | $650M | $642M |
| Current liabilities | $77.8M | $152M | $152M | $175M | $161M | $167M | $173M | $163M | $196M | $187M |
| Inventory | $197M | $235M | $235M | $248M | $272M | $225M | $303M | $278M | $265M | $299M |
| Property and equipment, net | $109M | $148M | $145M | $142M | — | — | — | — | — | — |
| Goodwill | $74.7M | $242M | $244M | $291M | $293M | $292M | $285M | $289M | $291M | $198M |
| Intangible assets | $20.7M | $91.3M | $73.8M | $86.3M | $67.5M | $50.7M | $33.6M | $22.4M | $16.1M | $14.0M |
| Total assets | $622M | $1.0B | $988M | $1.0B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.1B |
| Total liabilities | $86.1M | $650M | $549M | $580M | $674M | $651M | $638M | $669M | $670M | $621M |
| Preferred stock | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — | — | — |
| Shareholders' equity | $526M | $379M | $426M | $445M | $452M | $483M | $533M | $568M | $529M | $473M |
| Margins | ||||||||||
| Gross margin | 40.1% | 36.3% | 32.8% | 32.9% | 25.8% | 33.2% | 33.0% | 32.5% | 31.7% | 34.4% |
| Operating margin | 17.6% | 12.0% | 5.8% | 5.9% | −4.6% | 9.1% | 10.3% | 8.6% | 4.0% | −3.3% |
| EBITDA margin | 19.2% | 14.4% | 9.1% | 8.9% | −1.5% | 11.6% | 12.5% | 10.8% | 6.6% | −0.5% |
| Net margin | 11.0% | 7.4% | 3.6% | 2.0% | −7.8% | 2.1% | 3.5% | 5.3% | −6.0% | −8.3% |
| FCF margin | 7.3% | 7.9% | 8.4% | 6.7% | −1.4% | 9.5% | −0.5% | 9.8% | 2.5% | 2.2% |
| Returns | ||||||||||
| Return on capital | 14.6% | 7.5% | 5.8% | 4.1% | −3.3% | 6.2% | 7.1% | 9.4% | 2.7% | −3.2% |
| Return on capital employed | 20.0% | 9.4% | 5.3% | 5.3% | −3.4% | 7.6% | 8.7% | 7.1% | 3.2% | −3.0% |
| Return on equity | 13.0% | 11.4% | 6.8% | 3.6% | −12.9% | 3.7% | 6.0% | 8.6% | −8.9% | −14.0% |
| Return on assets | 11.0% | 6.2% | 2.7% | 1.5% | −5.3% | 1.5% | 2.6% | 3.9% | −4.0% | −6.1% |
| Return on tangible equity | 15.9% | 112.7% | 25.3% | 22.9% | −63.6% | 12.4% | 14.1% | 18.5% | −22.0% | −27.0% |
| Growth | ||||||||||
| Revenue growth | — | 12.6% | 10.8% | 0.9% | −5.4% | 10.8% | 5.0% | 4.0% | −9.2% | 4.1% |
| Net income growth | — | −24.7% | −46.7% | −43.6% | −473.5% | — | 74.1% | 56.4% | −203.0% | — |
| EPS growth | — | −25.3% | −47.1% | −44.4% | −472.5% | — | 69.8% | 46.6% | −212.1% | — |
| FCF growth | — | 21.4% | 18.0% | −19.7% | −119.8% | — | −105.7% | — | −76.7% | −7.8% |
| Share count change | — | 0.8% | 1.1% | 0.5% | 0.5% | 3.9% | 3.2% | 20.9% | −18.9% | 1.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | −0.3x | 4.0x | 4.8x | 5.3x | — | 3.1x | 3.0x | 2.6x | 4.7x | — |
| Debt / equity | 0.0x | 1.3x | 0.9x | 0.9x | 1.0x | 0.9x | 0.8x | 0.8x | 0.8x | 0.8x |
| Interest coverage | 57.4x | 6.8x | 2.1x | 2.2x | −1.1x | 1.8x | 2.2x | 2.6x | 1.1x | −0.8x |
| Current ratio | 4.6x | 3.3x | 3.0x | 2.5x | 3.3x | 3.3x | 3.5x | 4.0x | 3.3x | 3.4x |
| Quick ratio | 2.1x | 1.7x | 1.5x | 1.1x | 1.6x | 2.0x | 1.8x | 2.3x | 2.0x | 1.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.7% | 2.9% | 2.6% | 2.5% | 3.2% | 1.8% | 2.5% | 2.3% | 3.3% | 2.7% |
| Stock comp / revenue | 1.5% | 1.2% | 1.3% | 1.5% | 1.8% | 1.7% | 1.6% | 1.5% | 1.9% | 1.8% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 3.0 | 5.0 | 5.0 | 3.0 | 8.0 | 6.0 | 5.0 | 3.0 | 6.0 |
| Altman Z'' | 10.6 | 3.4 | 3.4 | 3.0 | 2.6 | 3.5 | 4.0 | 4.2 | 3.6 | 3.3 |
| Accruals ratio | −0.9% | −2.8% | −5.7% | −5.6% | −6.5% | −6.6% | 1.1% | −5.0% | −7.8% | −9.7% |
Source: SEC EDGAR XBRL filings (CIK 0001681622). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
